ReviewNeuroscience bulletin2026
Disruptions in RNA Splicing: A Key Regulator of Cognitive Impairment in Perioperative Neurocognitive Disorders.
Review in Neuroscience bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perioperative neurocognitive disorders (PND) encompass a spectrum of cognitive impairments that emerge during the perioperative period. The pathogenesis of PND is multifactorial, involving complex interactions between neuroinflammation, impairment of synaptic plasticity, dysregulation of brain-derived neurotrophic factor (BDNF) signaling, oxidative stress, and mitochondrial dysfunction. RNA splicing is increasingly recognized as a critical player in nervous system function and dysfunction. In this review, we explore the role of RNA splicing in modulating the major pathogenic mechanisms of PND. We highlight how aberrant splicing events promote neuroinflammation by altering the expression of pro-inflammatory genes, disrupt synaptic plasticity by modifying the profiles of synaptic proteins and neurotransmitter receptors, and impair the expression and function of BDNF. Additionally, RNA splicing abnormalities exacerbate oxidative stress and mitochondrial dysfunction, further amplifying neuronal damage. By elucidating the intricate interactions between RNA splicing and these core pathological processes, this review reveals the close association between RNA splicing dysregulation and the molecular underpinnings of PND, and highlights its potential regulatory role in PND pathogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.